Back
The Financial Select Sector SPDR® ETF Vs. Spyre Therapeutics Industry Stock Comparison
Buy
64
XLF
The Financial Select Sector SPDR® ETF
Last Price:
45.15
Seasonality Move:
4.81%
Buy
59
SYRE
Spyre Therapeutics
Last Price:
28.46
Seasonality Move:
-2.85%
Buy
64
The Financial Select Sector SPDR® ETF (XLF)
is a Buy
Is The Financial Select Sector SPDR® ETF a Buy, Sell or Hold?
- The current The Financial Select Sector SPDR® ETF [XLF] share price is $45.02. The Score for XLF is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- XLF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $29.04. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
XLF Stock Price Chart
What is The Financial Select Sector SPDR® ETF's stock price today?
-
The The Financial Select Sector SPDR® ETF share price today is $45.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XLF is experiencing slight buying pressure.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $29.04
The current trend is moderately bearish and SYRE is experiencing slight buying pressure.
XLF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 54.28 | Buy |
Chaikin Money Flow: | 14606554 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (44.48 - 45.42) | Buy |
Bollinger Bands (100): | (41.23 - 44.27) | Buy |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 53.02 | Buy |
Chaikin Money Flow: | 71063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.98 - 29.52) | Buy |
Bollinger Bands (100): | (25.44 - 33.84) | Sell |
XLF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.27 | Sell |
20-day SMA: | 45.05 | Sell |
50-day SMA: | 43.92 | Buy |
200-day SMA: | 41.12 | Buy |
8-day EMA: | 45.1 | Sell |
20-day EMA: | 44.88 | Buy |
50-day EMA: | 44.05 | Buy |
200-day EMA: | 41.14 | Buy |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.1 | Sell |
20-day SMA: | 28.66 | Buy |
50-day SMA: | 27.88 | Buy |
200-day SMA: | 29.31 | Sell |
8-day EMA: | 28.88 | Buy |
20-day EMA: | 28.56 | Buy |
50-day EMA: | 28.37 | Buy |
200-day EMA: | 27.36 | Buy |
The Financial Select Sector SPDR® ETF Earnings Growth & XLF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
The Financial Select Sector SPDR® ETF Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |